Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Modulating polo-like kinase 1 as a means for cancer chemoprevention Schmit TL; Ledesma MC; Ahmad NPharm Res 2010[Jun]; 27 (6): 989-98Naturally occurring agents have always been appreciated for their medicinal value for both their chemopreventive and therapeutic effects against cancer. In fact, the majority of the drugs we use today, including the anti-cancer agents, were originally derived from natural compounds, either in their native form or modified to enhance their bioavailability or specificity. It is believed that for maximum effectiveness, it will useful to design novel target-based agents for chemoprevention as well as the treatment of cancer. Recent studies have shown that the serine/threonine kinase polo-like kinase (Plk) 1 is widely overexpressed in a variety of cancers and is being increasingly appreciated as a target for cancer management. Additionally, several chemopreventive agents have been shown to inhibit Plk1 in cancer cells. In this review, we will discuss if Plk1 could also be a target for designing novel strategies for cancer chemoprevention.|Animals[MESH]|Anticarcinogenic Agents/*pharmacology/therapeutic use[MESH]|Cell Cycle Proteins/antagonists & inhibitors/*metabolism[MESH]|Chemoprevention[MESH]|Humans[MESH]|Neoplasms/enzymology/*prevention & control[MESH]|Polo-Like Kinase 1[MESH]|Protein Kinase Inhibitors/*pharmacology/therapeutic use[MESH]|Protein Serine-Threonine Kinases/antagonists & inhibitors/*metabolism[MESH]|Proto-Oncogene Proteins/antagonists & inhibitors/*metabolism[MESH] |
